GOLDMAN SACHS GROUP INC - ASTERIAS BIOTHERAPEUTICS INC ownership

ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 56 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 339.00 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ASTERIAS BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2018$75,000
-11.8%
57,337
-8.8%
0.00%
Q2 2018$85,000
+214.8%
62,871
+426.8%
0.00%
Q4 2017$27,000
-35.7%
11,934
-3.9%
0.00%
Q3 2017$42,000
+16.7%
12,412
+17.3%
0.00%
Q1 2017$36,000
-82.9%
10,581
-78.6%
0.00%
Q3 2016$210,000
+118.8%
49,525
+23.9%
0.00%
Q2 2016$96,000
-11.1%
39,975
+43.9%
0.00%
Q3 2015$108,000
-65.4%
27,781
-40.0%
0.00%
Q1 2015$312,000
+169.0%
46,283
+29.1%
0.00%
Q4 2014$116,00035,8380.00%
Other shareholders
ASTERIAS BIOTHERAPEUTICS INC shareholders Q4 2015
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 5,292,156$7,674,0001.12%
Northeast Financial Consultants Inc 732,265$1,061,0000.36%
Family Management Corp 10,424$15,0000.01%
AJ WEALTH STRATEGIES, LLC 15,000$22,0000.01%
Poehling Capital Management, INC. 3,302$5,0000.00%
A.R.T. Advisors, LLC 48,692$70,0000.00%
Virtu Financial LLC 34,383$50,0000.00%
Founders Capital Management 3,000$4,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 151,854$220,0000.00%
BEACON INVESTMENT ADVISORY SERVICES, INC. 10,500$15,0000.00%
View complete list of ASTERIAS BIOTHERAPEUTICS INC shareholders